SARS-CoV-2 spike-protein targeted serology test results and their association with subsequent COVID-19-related outcomes

IMPORTANCE: In the absence of evidence of clinical utility, the United States' Centers for Disease Control and Prevention does not currently recommend the assessment of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike-protein antibody levels. Clinicians and their patients, esp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufman, Harvey W., Letovsky, Stanley, Meyer, William A., Gillim, Laura, Assimon, Magdalene M., Kabelac, Carly A., Kroner, John W., Reynolds, Shannon L., Eisenberg, Marcia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407563/
https://www.ncbi.nlm.nih.gov/pubmed/37559735
http://dx.doi.org/10.3389/fpubh.2023.1193246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407563/
https://www.ncbi.nlm.nih.gov/pubmed/37559735
http://dx.doi.org/10.3389/fpubh.2023.1193246

Ejemplares similares